patents

Comprehensive Conference Coverage with Cortellis for Competitive Intelligence

Our global conference coverage team is made up of scientific specialists and industry professionals. They understand you want comprehensive coverage and you want it now. Which is why we promise to deliver full reports within 28 days of a conference ending — but average 14. Be the first to act on the latest drug pipeline and patents information — with broad conference coverage from Cortellis for Competitive Intelligence.

Learn more.

Supreme Court grapples with patentability of human genes

Can human genes be patented?  That is the complex question the Supreme Court wrestled with during oral argument April 15.

The resolution of the question is likely to have an impact far beyond the immediate case before the court, some legal experts say.

(Westlaw users: Click here for more stories from Westlaw Journal Intellectual Property.) (more…)

2012 State of Innovation report

state of innovation

Innovation and change have always been key components of any successful company. You need to be different if not ground-breaking in order to get ahead. The 2012 State of Innovation tracks who’s leading the way in patent activity using the Thomson Reuters Derwent World Patents Index database.

Patents are really a proxy for innovation. Inventive ideas that are unprotected can’t be successfully commercialized. Therefore, by looking at patent activity, one gets a true picture of the innovative landscape, regardless of how commercially successful an invention is.

Read the full story at thomsonreuters.com.

An inside look at Apple’s patent portfolio

An Inside Look at Apple’s Patent Portfolio

What will future incarnations of the Apple iPhone reveal?

A new Thomson Reuters report, Inside the iPhone Patent Portfolio, details patent and litigation activity across Apple’s 1,298 mobile patents and provides insight into the company’s innovation roadmap.

The following are among the key findings in the report: (more…)

Merck asks Supreme Court to review ‘reverse payment’ decision

Pharma giant Merck & Co. is asking the U.S. Supreme Court to review a federal appeals court’s decision that payments by pharmaceutical companies to generic-drug manufacturers to delay the arrival of less expensive medicines should be viewed as evidence of an unlawful restraint of trade.

(Click here for the petition on Westlaw.)

Merck argues that the decision by the 3rd U.S. Circuit Court of Appeals creates a split among the courts of appeal and casts doubt on the validity of pharmaceutical patent settlements. (more…)

Scientists Want High Court to Resolve Federal Circuit Precedence Conflict

Decisions about patentability in cases before the Federal Circuit are based not on the merits of a patent but on which judges happen to hear the appeal, a group of scientists says in a petition to the U.S. Supreme Court.

According to the professors at the Yale University School of Medicine and the University College London Medical School, the Supreme Court must resolve an internal conflict in the Federal Circuit that results in the appeals court’s inconsistent adherence to high court precedent. (more…)

Apple’s Patent Claims – Graphic of the Day

Apple’s claims on infringements made by Samsung in their various mobile and tablet devices are categorized in three distinct groups: design, utility & trade dress. Today’s graphics provides some highlights for each of the three categories.

apple samsung

Click to enlarge

#Patents Trending

Richard Beales and Breakingviews columnists discuss Twitter’s new engineer-friendly patent strategy and how it might cool down the tech sector’s intellectual property wars.

Research Confirms China Leads World in Patent Applications, Trademark Filings

By tracking published patent applications, examining real-world trademark and copyright infringement issues and comparing the government policies and long-term innovation strategies of China to other world leaders, new reports from Thomson Reuters suggest that although China leads the world in patent and trademark filings, its status as a global player still faces challenges.

“Intellectual property is the bridge that connects innovation with economic growth,” said David Brown, president of the IP Solutions business of Thomson Reuters. “We’ve taken on this research as a means of identifying the point where innovation and creativity meet marketability, thus setting the stage for sustained economic development. By closely examining a wide variety of metrics, we can see China is clearly on that path, but there are significant milestones yet to be attained.”

Among the key findings detailed in the free Thomson Reuters China reports on patent and trademark trends:

  • China Now Leads World in Patent Filings: Published patent applications in China increased by 16.7 percent between 2006 and 2010; and this year’s patent activity secures China’s status as the world leader in patent application volume, as previously predicted by Thomson Reuters. Thomson Reuters projects that China will publish 493,000 patent applications annually by 2015.
  • Trademark Applications Surge: Since 2000, the number of trademarks registered in China has increased by more than 450 percent, far outpacing other nations, despite widespread counterfeiting and infringement.
     
  • Growing Influence in Scientific Literature: Over the last five years, there has been an 80 percent increase in Chinese scientific literature annual output, making China second in the world in published scientific papers. The United States, which currently has the highest overall output, grew by five percent.
  • Slow to Expand Globally: Chinese organizations are not protecting their inventions by filing patents globally at the same level as other innovation-minded countries. Currently, only 5.6 percent of China’s inventions are protected with global patent filings abroad, far less than the United States (48.8 percent) and Japan (38.7 percent).
     
  • China’s Corporate Innovation Lags: According to the Thomson Reuters Top 100 Global Innovators analysis, the most innovative companies in the world are based in the United States (40 percent), Europe (29 percent) and Japan (27 percent).
     
  • Global Brands Capitalize on Chinese Consumerism: In an economic environment that is expected to reach $4.3 trillion USD in retail spending by 2015, leading multinational companies have been among the top 20 trademark filers in China from 1976 through 2011.

The research findings are available in two new reports from the IP Solutions business of Thomson Reuters.  Invented in China assesses total patent volumes and highlights growing areas of innovation activity in China.  Special Report: Trademarks in China tracks trends in trademark activity in China over the last 20 years and analyzes trademark activities of the world’s leading brands.

This post originally ran on our Legal Current blog.

Top 10 Chinese Assignees in Pharma 2006 – 2010

Analysis of the top assignees in the Pharmaceutical sector is given in the graphic below. It is notable that seven of the top ten organizations are academic institutions.

Read the full report: Chinese Patenting: Report on the Current State of Innovation in China